结果 | PLA | N100mg | N高剂量 | N100mg + SE | N100mg + TI | N100mg + LR | N100mg + S |
PEP发生率(Ors) |
|
|
|
|
|
|
|
PLA | 1 | 0.37 (0.14, 0.83) | 0.32 (0.04, 2.16) | 0.38 (0.04, 3.06) | 0.22 (0.03, 1.57) | 0.26 (0.05, 1.08) | 0.27 (0.03, 2.19) |
N100mg | 2.68 (1.20, 6.90) | 1 | 0.84 (0.13, 5.80) | 1.01 (0.14, 7.63) | 0.57 (0.07, 5.36) | 0.69 (0.15,2.65) | 0.72 (0.10, 5.45) |
N高剂量 | 3.17 (0.41, 26.02) | 1.19 (0.17, 7.83) | 1 | 1.19 (0.08, 21.01) | 0.69 (0.03, 13.02) | 0.83 (0.07, 8.10) | 0.87 (0.05, 14.30) |
N100mg + SE | 2.62 (0.33, 24.97) | 0.99 (0.13,7.23) | 0.84 (0.05, 13.03) | 1 | 0.56 (0.03, 12.03) | 0.68 (0.05, 7.37) | 0.71 (0.04, 12.07) |
N100mg + TI | 4.60 (0.64, 36.70) | 1.75 (0.19, 14.95) | 1.46 (0.08, 28.47) | 1.78 (0.08, 33.00) | 1 | 1.21 (0.08, 13.49) | 1.25 (0.06, 24.61) |
N100mg + LR | 3.86 (0.93, 21.43) | 1.45 (0.38, 6.85) | 1.21 (0.12, 14.46) | 1.46 (0.14, 19.23) | 0.82 (0.07, 11.91) | 1 | 1.04 (0.09, 13.38) |
N100mg + S | 3.64 (0.46, 37.55) | 1.38 (0.18, 10.38) | 1.15 (0.07, 19.44) | 1.40 (0.08, 24.24) | 0.80 (0.04, 16.95) | 0.96 (0.07, 11.76) | 1 |